Evidence map›Paper›PMID 36824484›Full record

ArticleBiomaterials and biosystems2022

Natural language processing in toxicology: Delineating adverse outcome pathways and guiding the application of new approach methodologies.

Marie P F Corradi, Alyanne M de Haan, Bernard Staumont, Aldert H Piersma, Liesbet Geris, Raymond H H Pieters, Cyrille A M Krul, Marc A T Teunis

Abstract read
In one paragraph

Article in Biomaterials and biosystems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Adverse Outcome Pathways Mechanistically Describing Hepatotoxicity.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marie P F CorradiInnovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Heidelberglaan 7, Utrecht 3584 CS, the Netherlands.
Alyanne M de HaanInnovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Heidelberglaan 7, Utrecht 3584 CS, the Netherlands.
Bernard StaumontBiomechanics Research Unit, GIGA In Silico Medicine, University of Liège, Avenue de l'Hôpital 11, Liège 4000, Belgium.
Aldert H PiersmaCentre for Health Protection of the Dutch National Institute for Public Health and the Environment (RIVM), Heidelberglaan 8, Utrecht 3584 CS, the Netherlands.
Liesbet GerisBiomechanics Research Unit, GIGA In Silico Medicine, University of Liège, Avenue de l'Hôpital 11, Liège 4000, Belgium.
Raymond H H PietersInnovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Heidelberglaan 7, Utrecht 3584 CS, the Netherlands.
Cyrille A M KrulInnovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Heidelberglaan 7, Utrecht 3584 CS, the Netherlands.
Marc A T TeunisInnovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Heidelberglaan 7, Utrecht 3584 CS, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adverse Outcome Pathways (AOPs) are conceptual frameworks that tie an initial perturbation (molecular initiating event) to a phenotypic toxicological manifestation (adverse outcome), through a series of steps (key events). They provide therefore a standardized way to map and organize toxicological mechanistic information. As such, AOPs inform on key events underlying toxicity, thus supporting the development of New Approach Methodologies (NAMs), which aim to reduce the use of animal testing for toxicology purposes. However, the establishment of a novel AOP relies on the gathering of multiple streams of evidence and information, from available literature to knowledge databases. Often, this information is in the form of free text, also called unstructured text, which is not immediately digestible by a computer. This information is thus both tedious and increasingly time-consuming to process manually with the growing volume of data available. The advancement of machine learning provides alternative solutions to this challenge. To extract and organize information from relevant sources, it seems valuable to employ deep learning Natural Language Processing techniques. We review here some of the recent progress in the NLP field, and show how these techniques have already demonstrated value in the biomedical and toxicology areas. We also propose an approach to efficiently and reliably extract and combine relevant toxicological information from text. This data can be used to map underlying mechanisms that lead to toxicological effects and start building quantitative models, in particular AOPs, ultimately allowing animal-free human-based hazard and risk assessment.

Indexed as

Adverse Outcome PathwaysAOP, Adverse Outcome PathwayNAM, New Approach MethodologyNatural Language ProcessingNew Approach MethodologiesNLP, Natural Language ProcessingToxicology

Identifiers

PMID36824484
PMCPMC9934466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.